Financial Consulate’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Financial Consulate's VRTX Position: Q2 2026 in Review
Financial Consulate increased its Vertex Pharmaceuticals (VRTX) stake by 63% in Q2 2026, buying an estimated $2.22K and bringing the position to 13 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #789.
Financial Consulate first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Financial Consulate held 13 shares of Vertex Pharmaceuticals worth $6.46K as of Q2 2026.
- Financial Consulate bought 5 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.22K.
- Vertex Pharmaceuticals made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #789 holding.
- Financial Consulate first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.